Abstract
Ankylosing spondylitis and reactive arthritis are seronegative spondyloarthropathies, which are strongly associated with HLA-B27. Despite intensive investigation, the basis for this association is not clear. However, in recent years one favored hypothesis to explain this linkage has been that of molecular mimicry, i.e., sharing of linear or conformational epitopes common to microbial antigens and host structures. During the past few years several examples of molecular mimicry between HLA-B27 and microbial antigens have been described. Heat shock proteins, among others, have been considered as target candidates for autoimmune phenomena, because of the high degree of homology between bacterial and mammalian species. Reactive arthritis triggered byYersinia orSalmonella provides a unique model for studying the pathogenetic mechanisms underlying human inflammatory joint diseases in general, because the arthritogenic microbes are known and well-characterized. We have described two bacterial proteins that share amino acid homology with HLA-B27, namely YadA (Yersinia adhesin) and OmpH, outer surface proteins ofYersinia andSalmonella, respectively. Notably, the area of identity of these amino acid sequences is located in the same place on the HLA-B27 molecule as a hexapeptide identical betweenKlebsiella nitrogenase and HLA-B27, and a pentapeptide shared by aShigella flexneri protein and HLA-B27. We have investigated immune responses to a panel of synthetic peptides based on the HLA-B27-homologous portions of pathogen-specific antigens in patients with reactive arthritis and ankylosing spondylitis. One third of the patients have antibodies to the synthetic peptides. However, instead of recognizing the HLA-B27-homologous portion, the antibodies are directed against the flanking sequences of the synthetic peptides. The concept of the role of molecular mimicry between HLA-B27 and microbial antigens in the pathogenesis of spondyloarthropathies is discussed, with a conclusion that no convincing evidence for its significance exists at the present.
Similar content being viewed by others
References
Aho K, Ahvonen P, Lassus A, Sievers K, Tiilikainen A: HL-A antigen 27 and reactive arthritis. Lancet 1973;ii:157.
Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DCO, Sturrock RD: Ankylosing spondylitis and HLA-A 27. Lancet 1973;i:904–907.
Schlosstein L, Terasaki PI, Bluestone R, Pearson CM: High association of HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704–706.
Feltkamp TEW (ed): The Pathogenetic Role of HLA-B27. Scand J Rheumatol 1990;87 (suppl):1–163.
Tertti R, Toivanen P: Immune functions and inflammatory reactions in HLA-B27 positive subjects. Ann Rheum Dis 1991;50:731–734.
Toivanen P, Tertti R, Lahesmaa R: Arc HLA-B27-positive individuals immunologically unique? in Bálint G et al. (eds): Rheumatology, State of the Art. Amsterdam, Elsevier, 1992, pp 98–101.
Geczy AF, McGuigan LE, Sullivan JS, Edmonds JP: Cytotoxic T lymphocytes against disease-associated determinant(s) in ankylosing spondylitis. J Exp Med 1986;164:932–937.
Keat A: Is spondylitis caused byKlebsiella?. Immunol Today 1986;7: 144–149.
Lahesmaa-Runtala R, Toivanen A: Clinical spectrum of reactive arthritis; in Toivanen A, Toivanen P (eds): Reactive Arthritis. Boca Raton, CRC, 1988, pp 1–13.
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:506–512.
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987;329:512–518.
Parham P: Structure of class I MHC molecules: HLA B27 and disease. Scand J Rheumatol 1990;87(suppl): 11–20.
Parham P, Lomen CE, Lawler DA, Ways JP, Holmes N, Coppin HL, Salter RD, Wan AM, Ennis PD: The nature of polymorphism in HLA-A,B,C molecules. Proc Natl Acad Sci USA 1988;85:4005–4009.
Benjamin R, Parham P: Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990;11:137–142.
Grumet FC, Fendly BM, Engleman EG: Monoclonal anti-HLA-B27 antibody (B27M1): production and lack of detectable typing difference between patients with ankylosing spondylitis. Reiter's syndrome, and normal controls. Lancet 1981;ii: 174–176.
Karr RW, Hahn Y, Schwartz BD: Structural identity of human histocompatibility leukocyte antigen-B27 molecules from patients with ankylosing spondylitis and normal individuals. J Clin Invest 1982;69:443–450.
Choo SY, Antonelli P, Nisperos B, Nepom GT, Hansen JA: Six variants of HLA-B27 identified by isoelectric focusing. Immunogenetics 1986;23:24–29.
Coppin HL, McDevitt HO: Absence of polymorphism between HLA-B27 genomic exon sequences isolated from normal donors and ankylosing spondylitis patients. J Immunol 1986;137:2168–2172.
Breur-Vriesendorp BS, Dekker-Saeys AJ, Ivanyi P: Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: The disease is associated with a common determinant of the various B27 molecules. Ann Rheum Dis 1987;46: 353–356.
López de Castro JA: HLA-B27 and HLA-A2 subtypes: Structure, evolution and function. Immunol Today 1989;10:239–246.
Gorga JC, Madden DR, Prendergast JK, Wiley DC, Strominger JL: Crystallization and preliminary X-ray diffraction studies of the human major histocompatibility antigen HLA-B27. Proteins 1992;12:87–90.
Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC: Identification of self peptides bound to purified HLA-B27. Nature 1991; 353:326–329.
Madden DR, Gorga JC, Strominger JL, Wiley DC: The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 1991;353:321–325.
Oldstone MBA: Molecular mimicry and autoimmune disease. Cell 1987; 50:819–820.
van Eden W: Heat shock proteins in autoimmune arthritis: A critical contribution based on the adjuvant arthritis model. APMIS 1990;98: 383–394.
van Eden W, Thole JER, van der Zee R, Noordzij A, van Embden JDA, Hensen EJ, Cohen IR: Cloning the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988;331:171–173.
Billingham MEJ, Camey S, Butler R, Colston MJ: A mycobacterial 65 kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med 1990;171:339–344.
van den Broek MF, van Bruggen MCJ, Hogervorst EJM, van Eden W, van der Zee R, van der Berg WB: Protection against streptococcal cell wall induced arthritis by pretreatment with the mycobacterial 65 kD heat shock protein. J Exp Med 1989; 170:449–466.
Thompson SJ, Rook GAW, Brealey RJ, van der Zee R, Elson CJ: Autoimmune reactions to heat shock proteins in pristane induced arthritis. Eur J Immunol 1990;20:2479–2484.
Res PCM, Schaar CG, Breedveld PC, van Eden W, van Embden JDA, Cohen IR, de Vries RRP: Synovial fluid T cell reactivity against the 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet 1988;ii:478–480.
Res PCM, Telgt D, van Laar JM, Oudkerk Pool M, Breedveld FC, de Vries RRP: High antigen reactivity in mononuclear cells from sites of chronic inflammation. Lancet 1990; 336:1406–1408.
Res PCM, Orsini DLM, van Laar JM, Janson AAM, Abou-Zeid C, de Vries RRP: Diversity in antigen recognition byMycobacterium tuberculosis-reactive T cell clones from the synovial fluid of rheumatoid arthritis patients. Eur J Immunol 1991; 21:1297–1302.
Gaston JSH, Life PF, Jenner RJ, Colston MJ, Bacon PA: Recognition of a mycobacteria-specific epitope in the 65 kD protein by synovial fluid-derived T cell clones. J Exp Med 1990;17:831–841.
Shanafelt MC, Hindersson P, Soderberg C, Mensi N, Turck C, Webb D, Yssel H, Peitz G: T cell reactivity with theBorrelia burgdorferi 60-kDa heat shock protein in Lyme arthritis. J Immunol 1991;146:3985–3992.
Anzola J, Luft BJ, Gorgone G, Dattwyler RJ, Soderberg C, Lahesmaa R, Peltz G:Borrelia burgdorferi HSP70 homolog: Characterization of an immunoreactive stress protein. Infect Immun 1992;60:3704–3713.
Lahesmaa R, Skurnik M, Granfors K, Möttönen T, Saario R, Toivanen A, Toivanen P: Molecular mimicry in the pathogenesis of spondyloarthropathies. A critical appraisal of cross-reactivity between microbial antigens and HLA-B27. Br J Rheumatol 1992;31:221–229.
Hermann E, Lohse AW, van der Zee R, van Eden W, Mayet WJ, Probst P, Poralla T, Meyer zum Buschenfelde KH, Fleischer B: Synovial fluid-derivedYersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells. Eur J Immunol 1991;21: 2139–2143.
De Graeff-Meeder ER, van der Zee R, Rijkers GT, Schuurman HJ, Kuis W, Bijlsma JWJ, Zegers BJM, van Eden W: Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 1991;337:1368–1372.
Quayle AI, Wilson KB, Li SG, Kjeldsen-Kragh J, Oftung F, Shinnik T, Sioud M, Forre O, Capra JD, Natvig JB: Peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shock protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T cell clones from rheumatoid synovial fluid. Eur J Immunol 1992;22:1315.
Avakian H, Welsh J, Ebringer A, Entwistle CC: Ankylosing spondylitis HLA-B27 andKlebsiella. II. Cross-reactivity studies with human tissue typing sera. Br J Exp Pathol 1980;61:92–96.
Welsh J, Avakian H, Cowling P, Ebringer A, Wooley P, Panayi G, Ebringer R: Ankylosing spondylitis, HLA-B27 andKlebsiella I. Cross-reactivity studies with rabbit antisera. Br J Exp Pathol 1980;61:85–91.
Kone DH, Ogasawara M, Effros RB, Park MS, Waldord RL, Yu DTY: Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and arthritis using bacteria. Clin Exp Immunol 1985;61:503–508.
Chen JH, Kono DH, Yong Z, Park MS, Oldstone MB, Yu DT: AYersinia pseudotuberculosis protein which cross-reacts with HLA-B27. J Immunol 1987;139:3003–3011.
van Bohemen CG, Dinant HJ, Grumet FC, Landheer JE, Zanen HC: Significance of HLA-B27-like enterobacterial epitopes in the etiology of reactive arthritis; in Toivanen A, Toivanen P (eds); Reactive Arthritis, Boca Raton, CRC, 1988, pp 51–63.
Raybourne RB, Bunning VK, Williams KM: Reaction of anti-HLA-B monoclonal antibodies with envelope proteins ofShigella species. Evidence for molecular mimicry in the spondyloarthropathies. J Immunol 1988;140:3489–3495.
Williams KM, Raybourne RB: Demonstration of cross-reactivity between bacterial antigens and class I human leukocyte antigens by using monoclonal antibodies toShigella flexneri. Infect Immun 1990; 58:1774–1781.
Wakefield D, Easter J, Robinson P, Graham D, Penny R: Chlamydial antibody crossreactivity with peripheral blood mononuclear cells of patients with ankylosing spondylitis: the role of HLA-B27. Clin Exp Immunol 1986;63:49–57.
Ogasawara M, Kono DH, Yu DTY: Mimicry of human histocompatibility HLA-B27 antigens byKlebsiella pneumoniae. Infect Immun 1986; 51:901–908.
Williams KM, Hirofuji T, Raybourne RB, Shook DL, Trucksess MW, Yu DTY: Synthetic oligonucleotide probes complementary to the HLA-B variable region hybridize withKlebsiella pneumoniae. Microb Pathog 1989;6:277–286.
Yong Z, Zhang JJ, Schaack T, Chen S, Nakayama A, Yu DTY: A monoclonal anti-HLA-B27 antibody which is reactive with a linear sequence of the HLA-B27 protein is useful for the study of molecular mimicry. Clin Exp Rheumatol 1989;7:513–519.
van Bohemen CG, Grumet FC, Zanen HC: Identification of HLA-B27M1 and-M2 cross-reactive antigens inKlebsiella, Shigella andYersinia. Immunology 1984;52:607–610.
Grumet FC, Fendly BM, Fish L, Foung S, Engleman EG: Monoclonal antibody (B27M2) subdividing HLA-B27. Hum Immunol 1982; 5:61–72.
Schwimmbeck P, Yu DTY, Oldstone MBA: Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry withKlebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987;166: 173–181.
Husby G, Tsuchiya N, Schwimmbeck P, Keat A, Pahle JA, Oldstone MBA, Williams RC Jr. Cross-reactive epitope with nitrogenase in articular tissue of HLA-B27+ patients with ankylosing spondylitis. Arthritis Rheum 1989;32:437–445.
Stieglitz H, Fosmire S, Lipsky P: Bacterial epitopes involved in the induction of reactive arthritis. Am J Med 1988;85:56–58.
Stieglitz H, Fosmire S, Lipsky P: Identification of a 2 Md plasmid fromShigella flexneri associated with reactive arthritis. Arthritis Rheum 1989;32:937–946.
Lahesmaa R, Skurnik M, Vaara M, Leirisalo-Repo M, Nissilä M, Granfors K, Toivanen P: Molecular mimickry between HLA B27 andYersinia, Salmonella, Shigella andKlebsiella within the same region of HLA α1-helix. Clin Exp Immunol 1991; 86:399–404.
Gemski P, Lazere JR, Casey T: Plasmid associated with pathogenicity and calcium dependency ofYersinia enterocolitica. Infect Immun 1980; 27:682–685.
Gemski P, Lazere JR, Casey T, Wohlhieter JA. Presence of a virulence-associated plasmid inYersinia pseudotuberculosis. Infect Immun 1980;28:1044–1047.
Skurnik M: Expression of antigen encoded by the virulence plasmid ofYersinia enterocolitica under different growth conditions. Infect Immun 1985;47:183–190.
Bölin I, Portnoy DA, Wolf-Watz H: Expression of temperature-inducible outer membrane proteins ofYersinia. Infect Immun 1985;48:234–240.
Skurnik M, Bölin I, Heikkinen H, Piha S, Wolf-Watz H: Virulence plasmid-associated autoagglutination inYersinia spp. J Bacteriol 1984;158:1033–1036.
Balligand G, Laroche Y, Cornelis G: Genetic analysis of virulence plasmid from a serogroup 9Yersinia enterocolitica strain: Role of outer membrane protein P1 in resistance to human serum and autoagglutination. Infect Immun 1985;48:782–786.
Kapperud G, Namork E, Skarpeid HJ: Temperature-inducible surface fibrillae associated with the virulence plasmid ofYersinia enterocolitica andYersinia pseudotuberculosis. Infect Immun 1985;47:561–566.
Heesemann J, Gruter L: Genetic evidence that the outer membrane protein YOP1 ofYersinia enterocolitica mediates adherence and phagocytosis resistance to human epithelial cells. FEMS Microbiol Lett 1987;40:37.
Bukholm G, Kapperud G, Skurnik M: Genetic evidence thatYersinia outer membrane protein Yop1 gene mediates inhibition of the anti-invasive effect of interferon. Infect Immun 1990;58:2245–2251.
Rosqvist R, Forsberg Å, Rimpiläinen M, Bergman T, Wolf-Watz H: The cytotoxic protein YopE ofYersinia obstructs the primary host defence. Mol Microbiol 1990;4: 657–667.
Emödy L, Heesemann J, Wolf-Watz H, Skurnik M, Kapperud G, O'Toole P, Wadström T: Binding to collagen byYersinia enterocolitica andYersinia pseudotuberculosis: Evidence for yopA-mediated and chromosomally encoded mechanisms. J Bacteriol 1989;171:6674–6679.
Martinez RJ: Thermoregulation-dependent expression ofYersinia enterocolitica protein 1 imparts serum resistance toEscherichia coli K-12. J Bacteriol 1989;171:3732–3739.
Pærregaard A, Espersen F, Jensen OM, Skurnik M: Interactions betweenYersinia enterocolitica and rabbit ileal mucus: Growth, adhesion, penetration, subsequent changes in surface hydrophobicity and ability to adhere to ileal brush border membrane vesicles. Infect Immun 1991;59:253–260.
Pærregaard A, Espersen F, Skurnik M: Role of theYersinia outer membrane protein YadA in adhesion to rabbit intestinal tissue and rabbit intestinal brush border membrane vesicles. APMIS 1991;99:226–232.
Kapperud G, Namork E, Skurnik M, Nesbakken T: Plasmid-mediated surface fibrillae ofYersinia pseudotuberculosis andYersinia enterocolitica: Relationship to the outer membrane protein YOP1 and possible importance for pathogenesis. Infect Immun 1987;55:2247–2254.
Zaleska M, Lounatmaa K, Nurminen M, Wahlström E, Mäkelä PH: A novel virulence-associated cell surface structure composed of 47-kd protein subunits inYersinia enterocolitica. EMBO J 1985;4: 1013–1018.
Skurnik M, Wolf-Watz H: Analysis of theyopA gene encoding the Yop1 virulence determinants ofYersinia spp. Mol Microbiol 1989;3:517–529.
Koski P, Rhen M, Kantele J, Vaara M: Isolation, cloning, and primary structure of a cationic 16-kDa outer membrane protein ofSalmonella typhimurium. J Biol Chem 1989;264: 18973–18980.
Holck A, Kleppe K: Cloning and sequencing of the gene for the DNA-binding 17K protein ofEscherichia coli. Gene 1988;67:117–124.
Hirvas L, Coleman J, Koski P, Vaara M: Bacterial ‘histone-like protein I’ (HLP) is an outer membrane constituent? FEBS Lett 1990; 262:123–126.
Vaara M, Hirvas L, Koski P: The cationic 16-kDa outer membrane protein OmpH of enteric bacteria; in Nowotny A, Spitzer JJ, Ziegler EJ (eds): Cellular and Molecular Aspects of Endotoxin Reactions. Amsterdam, Excerpta Medica, 1990, pp 197–204.
Pearson WR, Lipman DJ: Improved tools for biological sequence analysis. Proc Natl Acad Sci USA 1988; 85:2444–2448.
Devereux J, Haeberli P, Smithies O: A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 1984;12:387–395.
Ewing C, Ebringer R, Tribbick G, Geysen HM: Antibody activity in ankylosing spondylitis sera to two sites on HLA B27.1 at the MHC groove region (within sequence 65–85), and to aKlebsiella pneumoniae nitrogenase reductase peptide (within sequence 181–199). J Exp Med 1990;171:1635–1647.
Pazmeny L, Rowland-Jones S, Huet S, Hill A, Sutton J, Murray R, Brooks J, McMichael A: Genetic modulation of antigen presentation by HLA-B27 molecules. J Exp Med 1992;175:361–369.
Powis SJ, Deverson EV, Coadwell WJ, Ciruela A, Huskisson NS, Smith H, Butcher GW, Howard JC: Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule. Nature 1992;357:211–215.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lahesmaa, R., Skurnik, M. & Toivanen, P. Molecular mimicry: Any role in the pathogenesis of spondyloarthropathies?. Immunol Res 12, 193–208 (1993). https://doi.org/10.1007/BF02918304
Issue Date:
DOI: https://doi.org/10.1007/BF02918304